Humanetics Corporation, based in Minneapolis, MN, is a leading biotechnology company specializing in the development of innovative radiation modulators and medical countermeasures. With a focus on oncology and inflammatory lung diseases, their cutting-edge technology and extensive research have positioned them as a key player in the field.
Driven by a team of experienced leaders and collaboration partners, Humanetics Corporation is dedicated to advancing the understanding of radiation modulators' mechanism of action, safety, and pharmacokinetics. Their pipeline includes promising treatments for non-small cell lung cancer, head and neck cancers, and prostate cancer, making them a significant contributor to the medical community's fight against these diseases.
Generated from the website